48
Participants
Start Date
September 25, 2024
Primary Completion Date
July 31, 2028
Study Completion Date
July 31, 2028
Part A: ATM-AVI Single Dose, Cohorts 1-4
Single intravenous infusion of aztreonam-avibactam over 3 hours to assess pharmacokinetics, safety, and toleration.
Part B: Multiple-dose ATM-AVI, Cohorts 1-4
Multiple intravenous infusions of aztreonam-avibactam over 3 hours, repeated every 6-8 hours up to 14 days to assess pharmacokinetics, safety, toleration, and efficacy.
RECRUITING
Chang Gung Medical Foundation-Linkou Branch, Taoyuan District
RECRUITING
Taichung Veterans General Hospital, Taichung
NOT_YET_RECRUITING
Sanatorio Sagrado Corazón, Ciudad Autónoma de Buenos Aires
NOT_YET_RECRUITING
Hospital del Niño Jesús, San Miguel de Tucumán
RECRUITING
Duke University - Main Hospital and Clinics, Durham
RECRUITING
Hsinchu Municipal Mackay Children's Hospital, Hsinchu
RECRUITING
Norton Children's Hospital, Louisville
RECRUITING
Novak Center for Children's Health, Louisville
RECRUITING
University of Louisville, Norton Children's Research Institute, Louisville
RECRUITING
Riley Hospital for Children at Indiana University Health, Indianapolis
RECRUITING
Schneider Children's Medical Center, Petah Tikva
RECRUITING
Memorial Hermann Hospital - Texas Medical Center, Houston
RECRUITING
The University of Texas Health Science Center at Houston, Houston
NOT_YET_RECRUITING
Children's Hospital Colorado, Aurora
RECRUITING
Children's Hospital of Orange County, Orange
RECRUITING
Medanta Hospital Lucknow, Lucknow
RECRUITING
Nirmal Hospital Pvt Ltd., Surat
RECRUITING
RajaRajeswari Medical College and Hospital, Bengaluru
RECRUITING
Institute of Child Health, Kolkata
RECRUITING
Rambam Health Care Campus, Haifa
RECRUITING
Tufts Medical Center, Boston
RECRUITING
Bristol Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital, New Brunswick
RECRUITING
Rutgers University, New Brunswick